These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20589201)

  • 1. Affects of "age at diagnosis" on coronary artery lesions in patients with incomplete kawasaki disease.
    Cho MA; Choi YJ; Jung JW
    Korean Circ J; 2010 Jun; 40(6):283-7. PubMed ID: 20589201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical manifestations and risk factors of coronary artery lesions in children with Kawasaki disease.
    Wang L; Zeng X; Chen B
    Medicine (Baltimore); 2023 Sep; 102(37):e34939. PubMed ID: 37713854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment change and coronary artery abnormality in incomplete Kawasaki disease.
    Nomura Y; Yashiro M; Masuda K; Nakamura Y
    Pediatr Int; 2020 Jul; 62(7):779-784. PubMed ID: 32219919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of clinical characteristics and related influencing factors of Kawasaki disease.
    Cai WJ; Ding SG
    Medicine (Baltimore); 2022 Dec; 101(52):e32430. PubMed ID: 36596080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study.
    Takahashi T; Sakakibara H; Morikawa Y; Miura M
    Pediatr Rheumatol Online J; 2015 Nov; 13(1):44. PubMed ID: 26530040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete kawasaki disease.
    Cho KH; Kang SJ
    Korean Circ J; 2014 Sep; 44(5):328-35. PubMed ID: 25278986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L; Yaping L; Xiufen H
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for coronary artery lesions in children with Kawasaki disease].
    Li Y; Wang XM; Liu YL; Shi K; Yang YF; Guo YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Dec; 14(12):938-41. PubMed ID: 23234782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017.
    Xie LP; Yan WL; Huang M; Huang MR; Chen S; Huang GY; Liu F
    J Epidemiol; 2020 Oct; 30(10):429-435. PubMed ID: 31548437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explorative case control study on the associations of serum vitamin D3, folic acid and vitamin B12 levels on Kawasaki disease and coronary artery lesions.
    Chen Y; Liu X; Li B; Li J; Meng L; Ye C; Han L; Li H; Deng LL; Su Z; Zhang X
    Front Nutr; 2024; 11():1402316. PubMed ID: 38919394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Analysis of Anti-Cardiolipin Antibody/D Dimer/C-Reactive Protein and Coronary Artery Lesions/Multiple-Organ Damage in Children With Kawasaki Disease.
    Xu YM; Chu YQ; Wang H
    Front Pediatr; 2021; 9():704929. PubMed ID: 34660478
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J; Jiang H; Lu M
    Arch Argent Pediatr; 2020 Oct; 118(5):327-331. PubMed ID: 32924395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC; Corsello G; Prinzi E; Cimaz R
    Ital J Pediatr; 2016 Nov; 42(1):92. PubMed ID: 27806720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.